Special Issue "Advances in Diagnosis and Treatment of Cardiac Arrhythmias"

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: 28 February 2023 | Viewed by 480

Special Issue Editors

Dr. Fabrizio Guarracini
E-Mail Website
Guest Editor
Department of Cardiology, S. Chiara Hospital, 38122 Trento, Italy
Interests: cardiac electrophysiology; cardiac devices; ventricular tachycardia; atrial fibrillation; left atrial appendage closure
Dr. Patrizio Mazzone
E-Mail Website
Guest Editor
Cardiothoracovascular Department, Electrophysiology Unit, Niguarda Hospital, Piazza Ospedale Maggiore 1, 20162 Milano, Italy
Interests: cardiac electrophysiology; cardiac devices; ventricular tachycardia; atrial fibrillation; left atrial appendage closure
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

The diagnosis and treatment of cardiac arrhythmias are constantly evolving in daily clinical practice. Patients with cardiac arrhythmias such as atrial fibrillation or ventricular tachycardia often require advanced multidisciplinary assessments and treatments with the collaboration of cardiac surgeons for hybrid ablations or hemodynamic support. The use of the latest technologies in the field of cardiac electrophysiology and cardiac devices has allowed for safer treatments with better results in the follow-up of patients affected by different heart diseases. This Special Issue “Advances in Diagnosis and Treatment of Cardiac Arrhythmias” will cover a selection of recent research topics and updated manuscripts on the innovations in the field of interventional and pharmacological treatment of cardiac arrhythmias.

Dr. Fabrizio Guarracini
Dr. Patrizio Mazzone
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • atrial fibrillation
  • ventricular tachycardia
  • cardiac devices
  • cardiac electrophysiology

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
Post-Dilatation of New-Generation Self-Expandable Transcatheter Aortic Valves Does Not Increase Atrioventricular Conduction Abnormalities
Diagnostics 2023, 13(3), 427; https://doi.org/10.3390/diagnostics13030427 (registering DOI) - 24 Jan 2023
Viewed by 256
Abstract
The impact that post-dilatation has on the risk of experiencing conduction disorders after post-transcatheter aortic valve replacement with self-expanding valves (SE-TAVR) is unclear. We compared the rate of developing an atrioventricular (AV) high-grade conduction disorder and permanent pacemaker implantation (PPI) in post-TAVR patients [...] Read more.
The impact that post-dilatation has on the risk of experiencing conduction disorders after post-transcatheter aortic valve replacement with self-expanding valves (SE-TAVR) is unclear. We compared the rate of developing an atrioventricular (AV) high-grade conduction disorder and permanent pacemaker implantation (PPI) in post-TAVR patients undergoing post-dilatation. We enrolled patients with severe symptomatic calcified aortic stenosis (CAS) who were undergoing SE-TAVR between 1 January 2016, and 19 April 2019 at a single French center. Of the 532 patients treated with SE-TAVR, 417 subjects (78.4%) received Corevalve Evolute R and 115 subjects (21.6%) received the latest-generation Corevalve Evolute Pro valve. In total, 104/532 patients (19.5%; 21.6% with Evolute R vs. 12.2% with Evolute Pro, p = 0.024) required post-dilatation. Evolut R was associated with an increased risk of post-dilatation (odds ratio 2.1 (1.01–4.33, p = 0.046)). We did not observe any post-dilatation increases in AV or in intra- and interventricular conduction disorders. In total, 26.1% of participants needed PPI within the first 30 post-procedure days (p = 0.449). Post-dilatation was not associated with a higher PPI risk (subdistribution hazard ratio 1.033 (0.726–1.471); p = 0.857). No significant differences existed between the groups in terms of one-year mortality (10.3%; p = 0.507). Post-dilatation in SE-TAVR did not increase the rate of electrical conduction disorders and PPI in the early implantation phase. The latest generation of SE-TAVR valves was associated with less need for post-dilatation. Full article
(This article belongs to the Special Issue Advances in Diagnosis and Treatment of Cardiac Arrhythmias)
Show Figures

Figure 1

Back to TopTop